Investor directory

Teuza

Founded in 1992, Teuza is a Venture capital fund (VC) publicly traded in the Tel Aviv stock exchange. Teuza invests in Venture companies in the fields of IT, software, communications, electronics, medical equipment and healthcare in all stages. Teuza's investments are usually in the range of $500,000-$4 million, sometimes in multiple rounds. Teuza's main interest is in companies that have breakthrough technologies, thus giving them an 'unfair advantage' in their fields, and a chance to become a world leader in their sector. Teuza's policy is to involve in our portfolio companies strategic partners from our broad business network, typically well-known multinational companies that bring added value. Teuza believes in a "hands on" approach to assist its portfolio companies. For that, it's involved in the ongoing management through: Board membership, active participation in setting strategy and tactics, recruitment of key positions, funding, budget decisions and more. Teuza's Chairman is Prof. Moshe Arens, Israel's former minister of defense, minister of foreign affairs and ambassador to the United States. Teuza is managed by Teuza management and development 1991 ltd, headed by its CEO, Mr. Avi Kerbs.
http://www.teuzafund.com
https://crunchbase.com/organization/teuza
https://linkedin.com/company/teuza
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=426547

Avi Kerbs

President and CEO

Moshe Zimmerman

CFO

10 past transactions

TytoCare

Seed Round in 2012
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

Digiflex

Series B in 2010
DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making -Ideal for narrow web applications printers -A great motivation to replace the traditional low quality film solution -The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track

TytoCare

Private Placement in 2020
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

Digiflex

Series A in 2009
DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making -Ideal for narrow web applications printers -A great motivation to replace the traditional low quality film solution -The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track

MediaBoost

Venture Round in 2010
MediaBoost takes an algorithmic approach to ad spend optimization, making the process of keyword bidding automatic for the advertiser. Rather than using rules of thumb, or trying to put guesstimates on the bid price for a certain keyboard, MediaBoost's flagship product, AdBooster, will do it for you.

TytoCare

Series B in 2015
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

MediaBoost

Series B in 2008
MediaBoost takes an algorithmic approach to ad spend optimization, making the process of keyword bidding automatic for the advertiser. Rather than using rules of thumb, or trying to put guesstimates on the bid price for a certain keyboard, MediaBoost's flagship product, AdBooster, will do it for you.

TytoCare

Venture Round in 2020
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

TytoCare

Merger/Acquisition in 2020
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.